Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP)

scientific article published on 01 May 2006

Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1055/S-2006-926564
P698PubMed publication ID16705508

P2093author name stringFleischhauer J
Helbig H
Barthelmes D
Bösch MM
Kurz-Levin MM
Sutter FK
P433issue5
P304page(s)376-378
P577publication date2006-05-01
P1433published inKlinische Monatsblaetter fuer AugenheilkundeQ15767651
P1476titleMacular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP)
P478volume223

Reverse relations

cites work (P2860)
Q46472946Exudative age-related macular degeneration: efficacy and limits of the different treatments
Q35924041Macular atrophy after combined intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization
Q33292976Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone
Q43118124Sequential combined treatment with intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation
Q86551292Two-year results of combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation

Search more.